As you navigate the challenges of prostate cancer and erectile dysfunction, remember that you are not alone. With advances in ...

Trusted source of information on Prostate Health that includes articles, news, videos, animations, quizzes, calculators and ...

The drug is already approved to treat non-metastatic castration-resistant prostate cancer (CRPC), but expansion into hormone-sensitive prostate cancer could unlock a sizeable new market for the drug.

TEL-AVIV, Israel and RALEIGH, N.C. - RedHill Biopharma Ltd. (NASDAQ: NASDAQ:RDHL), a specialty biopharmaceutical company with a market capitalization of $7.53 million, today announced the initiation ...

The trial will enroll 80 patients and aims to determine if opaganib can enhance the effectiveness of darolutamide, a treatment for prostate cancer which often develops resistance to standard care.

The identification of new drug resistance mechanisms and prostate cancer molecular subtypes based on genomic and proteomic analysis, as well as prognostic and predictive biomarkers, may further ...

In a video interview, William K. Oh, MD, director of precision medicine at Yale Cancer Center and Smilow Cancer Hospital discusses the latest breakthroughs in advanced prostate cancer treatment.

Savita Dandapani, MD, PhD, discusses the rationale behind a study evaluating the combination of radium-223, hormone therapy, and SBRT in metastatic castration-sensitive prostate cancer.

Common Hair Loss and Prostate Drug May Also Cut Heart Disease Risk in Men and Mice Feb. 20, 2024 — The drug finasteride, also known as Propecia or Proscar, treats male pattern baldness and ...

Maintaining a healthy urinary flow is essential for overall well-being, particularly as men age. As research in the field of ...